Trials / Unknown
UnknownNCT04405869
Thromboembolic Events in Severe COVID-19 Patients
Incidence of Thromboembolic Events and Prognosis of COVID-19 Patients Hospitalized in Intensive Care Units in France
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The main objective of this study is to describe the incidence of thromboembolic events in a population of patients hospitalized in intensive care units in France for severe COVID-19. The secondary objective of this study is to describe the evolution of hemostasis parameters during the first two weeks of intensive care hospitalization and to evaluate the influence of different anticoagulation regimens on these parameters and on the incidence of thromboembolic events
Conditions
Timeline
- Start date
- 2020-04-29
- Primary completion
- 2021-04-01
- Completion
- 2021-04-01
- First posted
- 2020-05-28
- Last updated
- 2020-05-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04405869. Inclusion in this directory is not an endorsement.